dual glp-1/gip receptor agonists Agonist | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) Free Comparison Chart: GLP-1 and

As fat accumulates around internal organs, it disrupts metabolic signalling, promotes inflammation, and impairs liver and cardiovascular function

Tanaka M, Matsuo Y, Yamakage H, Masuda S, Terada Y, Muranaka K, Wada H, Hasegawa K, Shimatsu A, Satoh-Asahara N

A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure or type 2 diabetes

Heart disease is the leading cause of death in women

3,507 GLP-1RAs reduce liver fat accumulation by activating AMPK, which inhibits fatty acid synthesis enzymes and promotes fatty acid -oxidation, thus diminishing lipid droplet accumulation in hepatocytes

This isn't a flaw in berberine, it's just how compounds that work through cellular metabolism rather than receptor binding tend to behave